Advanced Search
Contact | Corporate | Help

FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL)

Sponsors:
  • Hoffmann-La Roche
  • Biogen Idec
  • Genentech
Phases:
  • Phase III
IndicationsAcronym:
  • Chronic Lymphocytic Leukemia
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: rituximab
  • Drug: Fludarabine
  • Drug: Cyclophosphamide
Enrollment:
552

Additional information about NCT00090051.


SourceSolution © 2008-2012